How AI vision inspection is transforming medical device quality assurance (part I)

Published: 22-Sep-2025
Manufacturing Pharma 5.0

AI-powered vision inspection is revolutionising medical device quality assurance by overcoming the limitations of traditional methods and delivering faster, more accurate results

You need to be a subscriber to read this article.
Click here to find out more.

According to Market.US, the AI visual inspection system market is experiencing substantial growth and is projected to expand from $15.48 billion in 2023 to $89.7 billion by 2033 (with a robust CAGR of 19.62%).

North America currently leads the sector, accounting for 36.81% of the total share in 2023, representing $5698.5 million in revenue. 

Why traditional inspection falls short

Medical device manufacturing allows zero room for error. Every implant, surgical instrument and diagnostic device must meet uncompromising standards because patient lives depend on it.

Although conventional inspection methods have played a role, they fall short in today’s high-precision, high-volume environment (Figure 1).

Carl Lewis, Senior Product Manager at Rockwell Automation, reports. 

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.
See more

You may also like

Manufacturing

Beyond Pharma 4.0: pharma manufacturing and Industry 5.0

Read more
There’s a saying that the only constant in life is change. In terms of manufacturing technology, Industry 4.0 represents the most recent fundamental change, presenting a vision of smart manufacturing, near-complete automation, fully optimised processes and, ultimately, the “lights out” factory. Heather Coglaiti, Life Sciences Industry Leader, and Dan UpDyke, Strategic Marketing Manager at Rockwell Automation, report

Trending Articles

  1. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste
  2. Sapio Sciences introduces world’s first 3rd-generation ELN Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
  3. Labtex Labtex is a specialist laboratory and process chemistry equipment solutions provider. A dynamic team of professionals with expertise in research and process development across a wide range of industries and disciplines.
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Balancing innovation and accessibility in amino acid testing Butterworth Laboratories expands analytical capabilities to support compliance with Ph. Eur. standards

Upcoming event

POWTECH

23-25 September 2025 | Exhibition | Nuremberg, Germany See all

You may also like

Manufacturing

Beyond Pharma 4.0: pharma manufacturing and Industry 5.0

There’s a saying that the only constant in life is change. In terms of manufacturing technology, Industry 4.0 represents the most recent fundamental change, presenting a vision of smart manufacturing, near-complete automation, fully optimised processes and, ultimately, the “lights out” factory. Heather Coglaiti, Life Sciences Industry Leader, and Dan UpDyke, Strategic Marketing Manager at Rockwell Automation, report
Manufacturing

Edge computing in life sciences: delivering reliability

How RoviSys deployed Stratus Edge Computing to eliminate downtime and data loss, converge OT/IT and reduce FAT/SAT times from weeks to days for a life sciences company
Manufacturing

Delivering manufacturing agility with Pharma 4.0 transformation

According to rarediseases.org, there are some 7000 rare diseases that affect one in every 10 Americans. It’s a sobering statistic that illustrates how biopharma companies are being forced to tackle more diseases on more fronts than at any point in history, reports Heather Coglaiti, Life Sciences Industry Leader at Rockwell Automation
Manufacturing

Why digitally transformed businesses are best positioned to react to COVID-19

The World Health Organization’s declaration of coronavirus (COVID-19) as a global pandemic is unprecedented, a situation the like of which has not been seen in generations. Its effects have been felt worldwide and its exponential escalation has had a huge impact on the ability of health services to cope with the volume of cases. Billy Sisk, Life Sciences Industry Manager EMEA, Rockwell Automation, reports
Manufacturing

Rockwell acquires Italian ASEM to advance digital automation

By acquiring ASEM, Rockwell expands its European presence in the control and visualisation hardware and software segment
Manufacturing

Lonza digitises Capsugel manufacturing environments

The Switzerland-based company chose Rockwell’s PharmaSuite Manufacturing Execution System (MES) software to help avoid disruptions during high volume periods
Manufacturing

GE Healthcare and Rockwell collaborate on next-gen bioprocessing automation

Companies will combine automation, IT and single-use solution expertise to streamline workflows resulting in faster times to market
Subscribe now